GHUCCTS

Event Calendar

Share This

Dean's Seminar Series: Nature, Nurture and Fatty Liver Disease

Date Thu, Jan 28
Time 4: 00 PM - 5: 00 PM
Location Zoom


Headshot of Dr. Helen Hobbs smiling, wearing a gold necklace and gold earrings.The Georgetown University Medical Center (GUMC) Office of the Dean for Research is proud to present the Dean's Seminar Series. This seminar features Helen H. Hobbs, MD, Investigator, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center. Dr. Hobbs will discuss "Nature, Nurture and Fatty Liver Disease".

Fatty liver disease (FLD) is a burgeoning health problem that affects one-third of adults and an increasing number of children in the United States. The hallmark of FLD is the accumulation of triglyceride in cytoplasmic lipid droplets of hepatocytes (steatosis). In a subset of individuals, steatosis elicits an inflammatory response (steatohepatitis), which can progress to cirrhosis and hepatocellular carcinoma. Incomplete understanding of the pathogenesis of FLD has limited the development of therapies to arrest progression of the disorder. Our lab has used a variety of genetic approaches to identify genetic differences contributing to the development of FLD. The pathogenic mechanisms contributing to the genetic susceptibility factors we have identified and the implications of our findings for the prevention and treatment of FLD will be discussed.


Accreditation: In support of improving patient care, this activity has been planned and implemented by MedStar Health and Georgetown University Medical Center. MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation: MedStar Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Upcoming Events
This Duke Clinical Research Institute (DCRI) NIH "Rethinking Clinical Trials" Grand Rounds features Pamela Tenaerts, MD, MBA, Executive Director, Clinical Trials Transformation Initiative. Dr. Tenaerts will discuss "How CTTI & the Clinical Trials Community Have Risen to Meet the Challenge of the COVID-19 Pandemic".
Jan 21
The Georgetown University Medical Center (GUMC) Office of the Dean for Research is proud to present the Dean's Seminar Series. This seminar features Peter Tontonoz, MD, PhD, Professor, Pathology & Laboratory Medicine, UCLA Health. Dr. Tontonoz will discuss "New Pathways for Cellular and Systemic Lipid Transport".
Jan 22
This month's MHRI-GHUCCTS Monthly Statistical Seminar Series features Dr. Paul Kolm, Associate Director in the Department of Biostatistics and Biomedical Informatics at MedStar Health Research Institute. Dr. Kolm will discuss meta-analysis. Meta-analysis combines the results of several studies to overcome small samples of individual studies and estimate a "true" effect size of some treatment, therapy, etc. There has been a substantial increase in the number of meta-analyses published in the past few years, but many appear to not understand the potential problems of the method and draw incorrect conclusions. We will examine the method, potential problems, and what can and cannot be inferred from the results.
Jan 28
Dean's Seminar Series: Nature, Nurture and Fatty Liver Disease  Jan 28, 2021  4: 00 PM - 5: 00 PM  Zoom
The Georgetown University Medical Center (GUMC) Office of the Dean for Research is proud to present the Dean's Seminar Series. This seminar features Helen H. Hobbs, MD, Investigator, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center. Dr. Hobbs will discuss "Nature, Nurture and Fatty Liver Disease".
Close